Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Concentra Biosciences, LLC Insider Profile
4 Followers
Concentra Biosciences, LLC, Ten Percent Owner at Jounce Therapeutics, holds 10.00K shares in Jounce Therapeutics (Ticker: JNCE).
Concentra Biosciences, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Concentra Biosciences, LLC's holdings
Insider Roles
Ten Percent Owner
Roles that Concentra Biosciences, LLC holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Concentra Biosciences, LLC
Concentra Biosciences, LLC's Trading History
List of latest transactions for each holding click on a transaction to see Concentra Biosciences, LLC's performance on stock
You May Also Like
Concentra Biosciences, LLC insider profile FAQ
What is the percentage of profitable transactions made by Concentra Biosciences, LLC?
The percentage of profitable transactions made by Concentra Biosciences, LLC is ―.
What is the average return per transaction made by Concentra Biosciences, LLC?
The average return per transaction made by Concentra Biosciences, LLC is ―.
What stocks does Concentra Biosciences, LLC hold?
Concentra Biosciences, LLC holds: JNCE stocks.
What was Concentra Biosciences, LLC’s latest transaction?
Concentra Biosciences, LLC latest transaction was an Uninformative Buy of $97.38M.
What was Concentra Biosciences, LLC's most profitable transaction?
Concentra Biosciences, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Concentra Biosciences, LLC's role in Jounce Therapeutics?
Concentra Biosciences, LLC's role in Jounce Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.